VX-001 (Vaccex)

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameVX-001 (Vaccex)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 8Toll like receptor 7
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVaccex Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaccex Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A